MetLife Investment Advisors »

Fate Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $165k 44k 3.74
2023-09-30 $93k 44k 2.12
2023-06-30 $210k 44k 4.76
2023-03-31 $251k 44k 5.70
2022-12-31 $444k 44k 10.09
2022-09-30 $986k 44k 22.41
2022-06-30 $1.1M 44k 24.78
2022-03-31 $1.7M 44k 38.77
2021-12-31 $1.7M 28k 58.51
2021-09-30 $1.7M 28k 59.27
2021-06-30 $2.5M 28k 86.79
2021-03-31 $2.3M 28k 82.45
2020-12-31 $2.6M 29k 90.92
2020-09-30 $1.2M 30k 39.97
2020-06-30 $923k 27k 34.29
2020-03-31 $598k 27k 22.22
2019-12-31 $527k 27k 19.58
2019-09-30 $361k 23k 15.52
2019-06-30 $566k 28k 20.30
2019-03-31 $490k 28k 17.57
2018-12-31 $358k 28k 12.84
2018-09-30 $583k 36k 16.28
2018-06-30 $262k 23k 11.35
2018-03-31 $225k 23k 9.75